1,441 results on '"Storck, William"'
Search Results
2. Supplementary Figure S3 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
3. Supplementary Table S3 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
4. Supplementary Data from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
5. Supplementary Table S8-S12 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
6. Supplementary Table S2 S4 S6 S7 from BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
7. The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity
8. BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
9. Selection and Characterization of Mutants Defective in DNA Methylation in Neurospora crassa
10. LSD1 prevents aberrant heterochromatin formation in Neurospora crassa
11. A Light-Inducible Strain for Genome-Wide Histone Turnover Profiling in Neurospora crassa
12. More growth for chemical earnings
13. Chemical earnings show increase
14. Earnings growth accelerates
15. A modest rise for chemical earnings
16. Chemical earnings in fourth quarter
17. United States: The chemical industry enters 2006 with many of the concerns it had in 2005
18. Chemical earnings growth slows
19. Earnings increase again for many firms: Overall, U.S. chemical makers continued solid earnings growth in the second quarter
20. Chemical earnings climb once again
21. Chemical firms see good quarter
22. Earnings soar, thanks to DOW: Industry leader masks still-lackluster performance of many chemical firms
23. Every silver lining has a cloud. Better earnings by 25 chemical firms hide continuing cost and demand problems
24. More gains in 2002 chemical earnings. Chemical companies post strong improvement in the fourth quarter on a good sales increase
25. Chemical earnings jump in quarter. Going up against a very weak third quarter a year ago, chemical company results surge
26. Chemical earnings tumble once again. Economic conditions conspire to torpedo fourth-quarter results; timing of recovery still uncertain
27. Earnings plunge at chemical companies
28. Fourth-quarter earnings plunge
29. Earnings Fall At Major Chemical Firms
30. Earnings rise for chemical companies; diversified firms' result also increase, while those at oil producers surge
31. Earnings rise for chemical companies. (leading companies)
32. Chemical earnings jump
33. Change at the top 75
34. Chemical Earnings Turn Up
35. Chemical earnings getting better
36. Chemical earnings continue to fall: but the decline is slower than in any three-month period during the past year
37. Earnings slump in second quarter
38. Earnings rise despite problems
39. Top 100: few changes at the top
40. Industry's bright outlook
41. Facts and figures for the chemical industry
42. Chemical company earnings growth slows in fourth quarter, stays strong
43. Earnings increases for chemical producers drive up profitability
44. Chemical industry outlook remains bright after solid gains in 1994
45. Chemical earnings post solid gains based on increased sales, higher prices
46. Chemical companies' earnings improve for fifth consecutive quarter
47. U.S. companies step up investment in Pacific Rim countries
48. Solid sales gains finally kick in for major chemical companies
49. Top 100 chemical producers post little sales growth
50. Big fourth-quarter earnings increase buoyed 1993 results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.